Vanda Pharmaceuticals, Inc. (VNDA)
5.43
+0.09
(+1.69%)
USD |
NASDAQ |
Sep 04, 16:00
5.43
0.00 (0.00%)
After-Hours: 20:00
Vanda Pharmaceuticals Debt to Equity Ratio : 0.1037 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1037 |
| March 31, 2026 | 0.0466 |
| December 31, 2025 | 0.0386 |
| September 30, 2025 | 0.0234 |
| June 30, 2025 | 0.0239 |
| March 31, 2025 | 0.023 |
| December 31, 2024 | 0.023 |
| September 30, 2024 | 0.0147 |
| June 30, 2024 | 0.0155 |
| March 31, 2024 | 0.0164 |
| December 31, 2023 | 0.0173 |
| September 30, 2023 | 0.0181 |
| June 30, 2023 | 0.0191 |
| March 31, 2023 | 0.02 |
| December 31, 2022 | 0.0211 |
| September 30, 2022 | 0.0215 |
| June 30, 2022 | 0.0227 |
| March 31, 2022 | 0.0238 |
| December 31, 2021 | 0.0245 |
| September 30, 2021 | 0.0258 |
| June 30, 2021 | 0.0268 |
| March 31, 2021 | 0.0283 |
| December 31, 2020 | 0.03 |
| September 30, 2020 | 0.0307 |
| June 30, 2020 | 0.0322 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0342 |
| December 31, 2019 | 0.0355 |
| September 30, 2019 | 0.0372 |
| June 30, 2019 | 0.0514 |
| March 31, 2019 | 0.0559 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Protagonist Therapeutics, Inc. | 0.011 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 412.47M |
| Total Liabilities (Quarterly) | 192.28M |
| Shareholders Equity (Quarterly) | 220.18M |
| Current Ratio | 1.612 |
| Net Debt Paydown Yield | -0.60% |